XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.22.1

SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2022
Accounting Policies [Abstract] |
Schedule of Service Fee Revenue | Our total service revenues during the three months ended March 31, 2022 and 2021 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):
| Three Months Ended March 31, |  |
2022 |  | 2021 |  |  |  |
Commercial insurance | $ | 188,465 |  |  | $ | 182,096 |  |  |  |  |
Medicare | 70,999 |  |  | 63,589 |  |  |  |  |
Medicaid | 9,087 |  |  | 8,451 |  |  |  |  |
Workers' compensation/personal injury | 12,449 |  |  | 10,399 |  |  |  |  |
Other patient revenue | 7,123 |  |  | 4,775 |  |  |  |  |
Management fee revenue | 5,508 |  |  | 5,219 |  |  |  |  |
Software revenue | 3,399 |  |  | 2,426 |  |  |  |  |
AI revenue | 599 |  |  | — |  |  |  |  |
Other | 5,647 |  |  | 2,622 |  |  |  |  |
Service fee revenue | 303,276 |  |  | 279,577 |  |  |  |  |
Revenue under capitation arrangements | 38,491 |  |  | 35,742 |  |  |  |  |
Total service revenue | $ | 341,767 |  |  | $ | 315,319 |  |  |  |  |
Schedule of Goodwill and Other Intangible Assets | Activity in goodwill for the three months ended March 31, 2022 is provided below (in thousands):
Balance as of December 31, 2021 | $ | 513,820 |
Goodwill from acquisitions | 57,215 |
Valuation adjustment | (296) |
Currency translation | (551) |
Balance as of March 31, 2022 | $ | 570,188 |
Goodwill balances at March 31, 2022 reflect additional goodwill arising from deferred tax liabilities recorded on our acquisitions of Aidence Holding B.V. and Quantib B.V. of $7.3 million. See Note 4, Business Combinations and Related Activity for more information.
Schedule of Effect of Derivative Instruments on Comprehensive Loss | A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):
For the three months ended March 31, 2022
Account |  | December 31, 2021 Balance |  | Amount of comprehensive loss recognized on derivative net of taxes |  | Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes |  | March 31, 2022 Balance |  | Location
Accumulated Other Comprehensive Loss, net of taxes |  | $ | (18,886) |  |  | $ | — |  |  | $ | 923 |  |  | $ | (17,963) |  |  | Equity
For the twelve months ended December 31, 2021
Account |  | December 31, 2020 Balance |  | Amount of comprehensive loss recognized on derivative net of taxes |  | Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes |  | December 31, 2021 Balance |  | Location
Accumulated Other Comprehensive Loss, net of taxes |  | $ | (22,581) |  |  | $ | — |  |  | $ | 3,695 |  |  | $ | (18,886) |  |  | Equity
A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps which remain ineffective is as follows (amounts in thousands):
For the three months ended March 31, 2022
Ineffective interest rate swap |  | Amount of gain recognized in income on derivative (current period ineffective portion) |  | Location of gain recognized in Income on derivative (current period ineffective portion) |  | Gross amount of loss reclassified from accumulated OCI into income (prior period effective portion) |  | Location of loss reclassified from accumulated OCI into income (prior period effective portion)
Interest rate contracts |  | $ | 20,819 |  |  | Other income (expense) |  | $ | (923) |  |  | Interest Expense
Schedule of Business Acquisitions by Acquisition, Contingent Consideration | A tabular presentation of the effect of contingent consideration on our condensed consolidated balance sheet is as follows (amounts in thousands):
For the three months ended March 31, 2022
Account |  | January 20, 2022 Balance |  | Amount of other non operating income recognized on contingent consideration |  | March 31, 2022 Balance |  | Location
Accrued Expenses |  | $ | — |  |  | $ | (501) |  |  | $ | 501 |  |  | Liabilities and Non Operating Income
Schedule of Fair Value of Assets and Liabilities | The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):
| As of March 31, 2022
Level 1 |  | Level 2 |  | Level 3 |  | Total
Current and long term assets |  |  |  |  |  |  |
2019 Swaps - Interest Rate Contracts | $ | — |  |  | $ | 4,500 |  |  | $ | — |  |  | $ | 4,500 |
| As of December 31, 2021
Level 1 |  | Level 2 |  | Level 3 |  | Total
Current and long term liabilities |  |  |  |  |  |  |
2019 Swaps - Interest Rate Contracts | $ | — |  |  | $ | 16,319 |  |  | $ | — |  |  | $ | 16,319 |
The table below summarize the estimated fair values of certain of our shares of common stock issued in our Quantib B.V. acquisition on January 20, 2022, and held back for indemnification purposes that are subject to fair value measurements and the classification of these liabilities on our condensed consolidated balance sheets, as follows (in thousands):
| As of March 31, 2022
Level 1 |  | Level 2 |  | Level 3 |  | Total
Long term liabilities |  |  |  |  |  |  |
113,303 shares of RadNet common stock | $ | — |  |  | $ | — |  |  | $ | 2,535 |  |  | $ | 2,535 |
The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):
| As of March 31, 2022
Level 1 |  | Level 2 |  | Level 3 |  | Total Fair Value |  | Total Face Value
First Lien Term Loans and SunTrust Term Loan | $ | — |  |  | $ | 753,769 |  |  | $ | — |  |  | $ | 753,769 |  |  | $ | 764,563 |
| As of December 31, 2021
Level 1 |  | Level 2 |  | Level 3 |  | Total Fair Value |  | Total Face Value
First Lien Term Loans and SunTrust Term Loan | $ | — |  |  | $ | 766,973 |  |  | $ | — |  |  | $ | 766,973 |  |  | $ | 767,875 |
Schedule of Earnings Per Share | Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):
| Three Months Ended March 31, |  |
2022 |  | 2021 |  |  |  |
Net income attributable to RadNet, Inc.'s common stockholders | $ | 3,013 |  |  | $ | 9,458 |  |  |  |  |
BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS |  |  |  |  |  |  |
Weighted average number of common shares outstanding during the period | 55,303,007 |  |  | 51,951,506 |  |  |  |  |
Basic net income per share attributable to RadNet, Inc.'s common stockholders | $ | 0.05 |  |  | $ | 0.18 |  |  |  |  |
DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS |  |  |  |  |  |  |
Weighted average number of common shares outstanding during the period | 55,303,007 |  |  | 51,951,506 |  |  |  |  |
Add nonvested restricted stock subject only to service vesting | 197,911 |  |  | 253,265 |  |  |  |  |
Add additional shares issuable upon exercise of stock options and contingently issuable shares | 861,275 |  |  | 624,170 |  |  |  |  |
Weighted average number of common shares used in calculating diluted net income per share | 56,362,193 |  |  | 52,828,941 |  |  |  |  |
Diluted net income per share attributable to RadNet, Inc.'s common stockholders | $ | 0.05 |  |  | $ | 0.18 |  |  |  |  |
Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive: |  |  |  |  |  |  |
Shares issuable upon the exercise of stock options: | 46,912 |  |  | 82,595 |  |  |  |  |
Schedule of Business Acquisitions | We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):
Entity | Date Acquired | Total Consideration | Property & Equipment | Right of Use Assets | Goodwill |  |  | Right of Use Liabilities
IFRC LLC *^ | 1/1/2022 | 3,922 | 2,121 | 1,295 | 1,801 |  |  | (1,295)
*Fair Value Determination is Final ^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, two of which were purchased separately by wholly owned RadNet subsidiaries. We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):
Entity | Date Acquired | Total Consideration | Property & Equipment | Right of Use Assets | Goodwill |  | Other Assets | Right of Use Liabilities
IFRC LLC*^ | 1/1/2022 | 4,800 | 2,103 | 857 | 2,697 |  | — | (857)
IFRC LLC*^ | 1/1/2022 | 8,200 | 2,910 | 1,703 | 5,271 |  | 19 | (1,703)
Total |  | 13,000 | 5,013 | 2,560 | 7,968 |  | 19 | (2,560)
*Fair Value Determination is Final ^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.
Schedule of Investment in Joint Ventures | The following table is a summary of our investment in joint ventures during the three months ended March 31, 2022 (in thousands):
Balance as of December 31, 2021 | $ | 42,229 |
Equity in earnings in these joint ventures | 2,517 |
Balance as of March 31, 2022 | $ | 44,746 |
Schedule of Joint Venture Investment and Financial Information | The following table is a summary of key balance sheet data for these joint ventures as of March 31, 2022 and December 31, 2021 and income statement data for the three months ended March 31, 2022 and 2021 (in thousands):
Balance Sheet Data: | March 31, 2022 |  | December 31, 2021
Current assets | $ | 37,119 |  |  | $ | 37,186 |
Noncurrent assets | 83,407 |  |  | 73,592 |
Current liabilities | (12,722) |  |  | (12,919) |
Noncurrent liabilities | (27,298) |  |  | (22,370) |
Total net assets | $ | 80,506 |  |  | $ | 75,489 |
Book value of RadNet joint venture interests | $ | 37,214 |  |  | $ | 34,930 |
Cost in excess of book value of acquired joint venture interests and other | 7,532 |  |  | 7,299 |
Total value of RadNet joint venture interests | $ | 44,746 |  |  | $ | 42,229 |
Income statement data for the three months ended March 31, | 2022 |  | 2021
Net revenue | $ | 34,411 |  |  | $ | 31,718 |
Net income | $ | 5,035 |  |  | $ | 4,803 |

X
- Definition Joint Venture Investment And Financial Information + References No definition available. + Details
Name: | rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock
Namespace Prefix: | rdnt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueByBalanceSheetGroupingTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments. + References No definition available. + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 + Details
Name: | us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 940 -SubTopic 320 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969 + Details
Name: | us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration